Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
2019 ◽
Vol 15
◽
pp. 100385
◽
2017 ◽
Vol 2
(7)
◽
pp. 21-23
◽